Improving lung cancer screening for Hispanic patients
Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
This study is testing ways to help Hispanic patients get screened for lung cancer more easily by providing education, support, and reminders.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | University of California, Irvine Academic / other |
| Locations | 10 sites (Anaheim, California and 9 other locations) |
| Trial ID | NCT06225414 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance lung cancer screening uptake among the Hispanic community by implementing a multi-level intervention. The intervention includes usual care, brief patient education, referrals to financial navigation resources, and patient reminders to encourage screening with low-dose computed tomography (LDCT). The focus is on addressing barriers such as language, health literacy, and access to healthcare that disproportionately affect Hispanic patients. By comparing the effectiveness of these interventions, the study seeks to improve early detection of lung cancer in this underserved population.
Who should consider this trial
Good fit: Ideal candidates for this study are Hispanic individuals aged 50-80 with a history of smoking and access to a primary care provider.
Not a fit: Patients with a prior history of lung cancer or those who have had a chest CT in the last 12 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase lung cancer screening rates among Hispanic patients, leading to earlier detection and improved survival outcomes.
How similar studies have performed: Other studies have shown success in implementing targeted interventions to improve cancer screening rates in underserved populations, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 50- 80 years of age. * Be able to speak English and Spanish * Must have a Primary Care Provider. * History of 20-pack year smoking history ( based on survey self-report) * Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self-report) * Resident of California Exclusion Criteria: * Prior history of lung cancer * Chest CT for any reason in the last 12 months based on self-report and UCI EMR * History of Alzheimer's disease or dementia
Where this trial is running
Anaheim, California and 9 other locations
- UCI Health Family Health Center - Anaheim — Anaheim, California, United States (Recruiting)
- UCI Health-Costa Mesa — Costa Mesa, California, United States (Recruiting)
- UCI Health-Irvine — Irvine, California, United States (Recruiting)
- UCI Health-Laguna hilla — Laguna Hills, California, United States (Recruiting)
- UCI Health-Newport — Newport Beach, California, United States (Recruiting)
- UCI Health SeniorHealth Center -Pavillion 4 — Orange, California, United States (Recruiting)
- UCI Medical Center, Pavilion 3 — Orange, California, United States (Recruiting)
- UCI Health Family Health Center - Santa Ana — Santa Ana, California, United States (Recruiting)
- UCI-Health Tustin — Tustin, California, United States (Recruiting)
- UCI Health-Yorba Linda — Yorba Linda, California, United States (Recruiting)
Study contacts
- Principal investigator: Gelareh Sadigh, MD — University of California, Irvine
- Study coordinator: Gelareh Sadigh, MD
- Email: GSADIGH@UCI.EDU
- Phone: 949-745-5066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.